WALTER DE BROUWER

WALTER DE BROUWER

WALTER DE BROUWER

CEO | Doc.ai

Walter De Brouwer is the cofounder and CEO of doc.ai , a blockchain conversational AI platform that performs deep learning computations on quantified biology to develop predictive analytics and personal health insights.

The company started in August 2016 and recently closed a successful Initial Coin Offering  to decentralize its AI and allow anyone to use it  to collect, predict and change for better health insights via predictive healthcare.

Walter is an entrepeneur and investor in tech and science and started his career as an entrepreneur started 28 years ago in Europe as the Publisher of Computer Magazine sold to VNU now 3i Group and Riverland Networks sold to Keyware Technologies.

Together with Nicholas Negroponte he founded Starlab SA, Europe’s premier Deep Future research lab on wearable computing, Quantum computation, computational genomicsand MPEG-21 (IP was sold to Philips). In 1993 he co-founded the European internet backbone company PING out of the European UNIX Users Group later EUnet International Ltd. which merged with Qwest Communications and went from NASDAQ to NYSE now Centurylink. In 1994 he had cofounded one of the pioneers of online job boards in Europe called Jobscape which merged into Stepstone ASA and completed an IPO in March 2000. In 2002 he took over Patronale Capitalisation NV  made it into a Fintech Life insurer, specializing in synthetic risk. In 2007 Nicholas Negroponte appointed De Brouwer to set up the EMEA branch of MIT’s NGO One Laptop per Child (OLPC).  De Brouwer negotiated with 14 Ministers of Finance and 9 Presidents in South and West Africa and eventually The Learning Center was transferred from Massachusetts Institute of Technology (MIT) in Boston to Kigali (Rwanda) Institute of Science and Technology (KIST).  The XO was the first 802.11 mesh-driven device in Africa.

Walter moved to Silicon Valley in 2011 to found Scanadu one of the first mobile health company building people centric and mobile medical devices (FDA pending) using machine learning. He served as the CEO of the company until April 2016, and continues to sit on its board of Directors, today he also serves as Chief Scientific Officer at GenLife, as scientific advisor to Ubiome, and sits on the board of TokenSoft.

Walter earned a master’s degree in Formal  Linguistics  (University of Ghent, Belgium) and a Ph.D. in Computational Semantics (“Bio-semiotics: The Biology of Language.  The search for the atomic unit of meaning”) from the Catholic University of Tilburg, the Netherlands.  He started as academic lecturer at the Jesuit University of Antwerp, Belgium (Machine Translation and Chomsky’s TGG), but left in 1989 to become an entrepreneur.